Search Results 3061-3070 of 26167 for oral

  1. A Study of the Metabolome and Microbiome Following Bariatric Surgery, and the Effect on Metabolism in Patients with Type 2 Diabetes - Mayo Clinic

    ... oral agents other than thiazolidinediones; Control group with type 2 diabetes or impaired fasting glucose who are not interested in pursuing surgical ...

  2. Ear infection (middle ear) - Diagnosis & treatment - Mayo Clinic

    A healthcare professional can often diagnose an ear infection based on symptoms and an exam. The exam likely includes looking inside the child's ears with a ...

  3. Preoperative Prayer Into Ambulatory Surgical Patients’ Experience and Its Impact on Patient Anxiety and Satisfaction - Mayo Clinic

    Able to give oral consent. Exclusion Criteria: Surgical outpatients < 18 years of age. Unable to read and speak English OR unable to communicate using ...

  4. Tigecycline (intravenous route) - Side effects & uses - Mayo Clinic

    Tigecycline injection is used to treat bacterial infections in many different parts of the body (eg, infections on the skin, stomach, or lungs). It works by ...

  5. Using a Web-Based Data Base System to Improve Patient Outcomes in Postural Orthostatic Tachycardia Syndrome - Mayo Clinic

    Mayo Clinic Arizona patients who do not sign Certificate of Confidentiality form and give oral consent; Person unable to give information for completion of ...

  6. HPV Infection Clinical Trials - Mayo Clinic Research

    ... oral or throat HPV infection. It is also unknown if certain sexual behaviors increase the risk of oral HPV infection. Female Patients and Female Partners ...

  7. TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study - Mayo Clinic

    ... oral contraceptive. Hormonal contraception must be started at least 1 full cycle prior to Baseline and continue for 180 days after the last dose of ...

  8. Deepi G. Goyal, M.D., M.H.A.

    Oral ExaminerAmerican Board of Emergency Medicine. 2001 - 2005. MemberPractice Committee, Department of Emergency Medicine. 2001 - 2005. MemberResearch ...

  9. Evaluation of the Safety and Efficacy of Eneboparatide (AZP-3601) in Patients With Chronic Hypoparathyroidism - Mayo Clinic

    ... oral calcium supplements between the two measurements. Thyroid-stimulating ... Use of oral bisphosphonates within 6 months of screening or intravenous ...

  10. A Study of Pembrolizumab Alone or Combined with CC-486 for Patients with Platinum-Resistant Ovarian, Fallopian Tube, or Peritoneal Cancer - Mayo Clinic

    The purpose of the study is to determine the best dose of CC-486 (oral azacitidine) combined with pembrolizumab for the treatment of platinum-resistant ...